OUR STORY
Awarded seed grant from
PLATCOM Malaysia to
kickstart venture in
commercializing genomics
and genetics technologies.
Signed collaboration agreement with Monash University Malaysia to provide funding on commercial genomics research & development.
Successful completion
of development of printed biosensor technology platform for portable molecular diagnostics.
Signed collaboration MoU with Infrastructure University Kuala Lumpur on aptamer in silico development platform.
Launching of commercial in silico design and validation platform for new aptamers in
diagnostics and therapeutics.
New chapter in Biogenes Technologies with seed investment from Antler S.E.A.
Biogenes received NTIS Sandbox 1 support from MTDC & MRANTI to undertake lab validation of Biogenes kit. MTDC invested RM250,000
Cradle Fund Malaysia identified Biogenes as a high potential deeptech startup and funded Biogenes RM2m from its CIP Accelerate to help upscale production of aptamers.
Upon successful completion of NTIS1, MTDC approved Biogenes application to receive NTIS Sandbox 3 which provides funding to upscale production of APTSENS test kits. MTDC made available RM3.36m for this purpose.
